Log In
Print
BCIQ
Print
Print this Print this
 

remogliflozin etabonate (BHV091009, KGT-1681) (formerly GSK189075)

  Manage Alerts
Collapse Summary General Information
Company Kissei Pharmaceutical Co. Ltd.
DescriptionSodium-glucose cotransporter 2 (SGLT2) inhibitor
Molecular Target Sodium-glucose cotransporter 2 (SGLT2)
Mechanism of ActionSodium-glucose cotransporter 2 (SGLT2) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today